Trevi Therapeutics
TRVI
TRVI
110 hedge funds and large institutions have $330M invested in Trevi Therapeutics in 2024 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 47 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8.89% more ownership
Funds ownership: 80.07% → 88.95% (+8.9%)
13% less call options, than puts
Call options by funds: $927K | Put options by funds: $1.06M
Holders
110
Holding in Top 10
1
Calls
$927K
Puts
$1.06M
Top Buyers
| 1 | +$17.1M | |
| 2 | +$13.5M | |
| 3 | +$12M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$10.7M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$10.3M |
Top Sellers
| 1 | -$8.88M | |
| 2 | -$6.18M | |
| 3 | -$3.39M | |
| 4 |
ABG
Ally Bridge Group
New York
|
-$2.23M |
| 5 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$1.54M |